2024

Markovinovic A, Martín-Guerrero SM, Mórotz GM, Salam S, Gomez-Suaga P, Paillusson S, Greig J, Lee Y, Mitchell JC, Noble W, Miller CCJ. Stimulating VAPB-PTPIP51 ER-mitochondria tethering corrects FTD/ALS mutant TDP43 linked Ca 2+  and synaptic defects. Acta Neuropathol Commun. 2024 12(1):32

Hartopp N, Markovinovic A, Miller CC, Gomez-Suaga P. Insight into endoplasmic reticulum-mitochondria contacts in human amyotrophic lateral sclerosis. Neural Regen Res. 2024 19(7):1407-1408.

2023

Mohovic N, Peradinovic J, Markovinovic A, Cimbro R, Minic Z, Dominovic M, Jakovac H, Nimac J, Rogelj B, Munitic I. Neuroimmune characterization of optineurin insufficiency mouse model during ageing. Sci Rep. 2023 Jul 22;13(1):11840

Peradinovic J, Mohovic N, Bulic K, Markovinovic A, Cimbro R, Munitic I. Ageing-Induced Decline in Primary Myeloid Cell Phagocytosis Is Unaffected by Optineurin Insufficiency. Biology (Basel). 2023 Feb 3;12(2):240

2022

Mórotz GM*, Martín-Guerrero SM*, Markovinovic A*, Paillusson S, Russell MRG, Machado PMP, Fleck RA, Noble W, Miller CCJ. The PTPIP51 coiled-coil domain is important in VAPB binding, formation of ER-mitochondria contacts and IP3 receptor delivery of Ca 2+  to mitochondria. Front Cell Dev Biol. 2022 Aug 31;10:920947 *Joint 1 st author

Hartopp N, Lau DHW, Martin-Guerrero SM, Markovinovic A, Mórotz GM, Greig J, Glennon EB, Troakes C, Gomez-Suaga P, Noble W, Miller CCJ. Disruption of the VAPB-PTPIP51 ER-mitochondria tethering proteins in post-mortem human amyotrophic lateral sclerosis. Front Cell DevBiol. 2022 Aug 16;10:950767

Prtenjaca N, Rob M, Alam MS, Markovinovic A, Stuani C, Buratti E, Munitic I. Optineurin Deficiency and Insufficiency Lead to Higher Microglial TDP-43 Protein Levels. Int J Mol Sci. 2022 Jun 19;23(12):6829

Martín-Guerrero SM, Markovinovic A, Mórotz GM, Salam S, Noble W, Miller CCJ. Targeting ER-Mitochondria Signaling as a Therapeutic Target for Frontotemporal Dementia and Related Amyotrophic Lateral Sclerosis. Front Cell Dev Biol. 2022 May 27;10:915931

Gomez-Suaga P,* Mórotz GM*, Markovinovic A*, Martín-Guerrero SM*, Preza E, Arias N, Mayl K, Aabdien A, Gesheva V, Nishimura A, Annibali A, Lee Y, Mitchell JC, Wray S, Shaw C, Noble W, Miller CCJ. Disruption of ER-mitochondria tethering and signalling in C9orf72-associated amyotrophic lateral sclerosis and frontotemporal dementia. Aging Cell. 2022 Feb;21(2) *Joint 1 st author

Markovinovic A, Greig J, Martín-Guerrero SM, Salam S, Paillusson S. Endoplasmic reticulum-

mitochondria signaling in neurons and neurodegenerative diseases. J Cell Sci. 2022 Feb 1;135(3)

2021

Harrison CB, Trevelin SC, Richards DA, Santos CXC, Sawyer G, Markovinovic A, Zhang X, Zhang M, Brewer AC, Yin X, Mayr M, Shah AM. Fibroblast Nox2 (NADPH Oxidase-2) Regulates ANG II (Angiotensin II)-Induced Vascular Remodeling and Hypertension via Paracrine Signaling to Vascular Smooth Muscle Cells. Arterioscler Thromb Vasc Biol. 2021 Feb;41(2)

2020

Prtenjaca N, Dominovic M, Peradinovic J, Sajn R, Markovinovic A, Munitic I. Optineurin dysfunction in amyotrophic lateral sclerosis: why so puzzling? Periodicum Biologorum. 2020 121-122:23-4

Béland LC*, Markovinovic A*, Jakovac H, De Marchi F, Bilic E, Mazzini L, Kriz J, Munitic I. Immunity in amyotrophic lateral sclerosis: blurred lines between excessive inflammation and inefficient immune responses. Brain Commun. 2020 Aug 13;2(2) *Joint 1 st author

2018

Markovinovic A, Ljutic T, Béland LC, Munitic I. Optineurin Insufficiency Disbalances Proinflammatory and Anti-inflammatory Factors by Reducing Microglial IFN-β Responses. Neuroscience. 2018 Sep 15;388:139-151

2017

Markovinovic A, Cimbro R, Ljutic T, Kriz J, Rogelj B, Munitic I. Optineurin in amyotrophic lateral sclerosis: Multifunctional adaptor protein at the crossroads of different neuroprotective mechanisms. Prog Neurobiol. 2017 Jul;154:1-20